Effectiveness of the Combination of Rituximab and Standard Chemotherapeutic Regimens in Previously Untreated Patients with Chronic Lymphocytic Leukaemia in Real-Life: Results from a Noninterventional Study (CILI Study)

Chronic lymphocytic leukemia (CLL) is one of the most common haematological malignancies exhibiting remarkable heterogeneity in clinical course. Rituximab added to standard chemotherapy has been proven to increase response rate and eventually survival among previously untreated CLL patients. CILI wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Szász, Róbert, Altai, Elvira, Pál, Katalin, Dombi, Péter, Iványi, János, Jakucs, János, Jóni, Natália, Illés, Árpád, Tárkányi, Ilona, Szerafin, László, Nagy, Zsolt, Farkas, Péter, Nagy, Ágnes, Piukovics, Klára, Ujj, György, Schneider, Tamás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449280/
https://www.ncbi.nlm.nih.gov/pubmed/30361908
http://dx.doi.org/10.1007/s12253-018-0474-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449280/
https://www.ncbi.nlm.nih.gov/pubmed/30361908
http://dx.doi.org/10.1007/s12253-018-0474-9

Ejemplares similares